To evaluate the incidence, patient characteristics, and 30-day post-procedural adverse events of endoscopic sleeve gastroplasty (ESG) using the MBSAQIP database.
Approach:
Study Population: Retrospective analysis of patients who underwent ESG or bariatric surgery from 2020 to 2023 using the MBSAQIP Participant Use File.
Study Variables: Collected demographic data, comorbidities, and 30-day post-procedural adverse events.
Statistical Analyses: Used univariate descriptive statistics, bivariate comparisons, and Poisson regression for data analysis.
Key Findings:
A total of 2371 patients included; mean age was 45 years, with 85.8% female.
ESG procedures increased by 50.5% from 386 in 2020 to 581 in 2023.
Mean BMI of patients undergoing ESG increased from 37.8 to 40.8 kg/m2.
Significant increase in patients with pre-procedural obstructive sleep apnea and anticoagulant use.
No statistically significant difference in the incidence of adverse events across the study period.
Interpretation:
Limitations:
Retrospective design may introduce bias.
Data limited to de-identified patient information, restricting detailed analysis.
